An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Trinity Biotech plc (Nasdaq: TRIB) will host an investor call on January 31, 2024, to provide an update on business operations. The call will focus on the company's diagnostic solutions for the point-of-care and clinical laboratory markets.
Positive
None.
Negative
None.
Conference Call Scheduled for Wednesday, January 31, 2024 at 8:30 AM ET
DUBLIN, Ireland, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, will host an investor call on Wednesday, January 31 at 8:30 AM ET to provide an update on business operations.
About Trinity Biotech Trinity Biotech develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. Trinity Biotech sells direct in the United States, Germany, France and the U.K. and through a network of international distributors and strategic partners in over 75 countries worldwide. For further information, please see the Company's website: www.trinitybiotech.com.
Contact:
Trinity Biotech plc Des Fitzgerald (353)-1-2769800
When is Trinity Biotech plc's investor call scheduled?
Trinity Biotech plc's investor call is scheduled for January 31, 2024.
What is the ticker symbol for Trinity Biotech plc?
The ticker symbol for Trinity Biotech plc is TRIB.
What will the investor call focus on?
The investor call will focus on providing an update on Trinity Biotech plc's business operations and their diagnostic solutions for the point-of-care and clinical laboratory markets.
How can I join the investor call?
To join the investor call, dial 1-877-407-0784 for the United States or 1-201-689-8560 for international participants. The conference ID is 13744109. There is also a webcast and CallMe feature available.
since its formation in 1992, trinity biotech has actively pursued the aim of becoming a leading player in the international diagnostics industry. through a combination of sustained, organic growth and an acquisition-led strategy, the company has assembled an impressive product portfolio and achieved the highest standards of excellence in developing, manufacturing and marketing diagnostic products. the test kits manufactured by trinity biotech are used in the clinical laboratory and point-of-care segments of the diagnostic market to detect infectious diseases, sexually transmitted diseases, autoimmune and haemoglobin disorders, and detect, monitor and control diabetes. the company is also a significant provider of raw materials to the life sciences industry. trinity biotech, which has its headquarters in ireland, employs in excess of 350 people and markets its portfolio of over 400 products to customers in 80 countries around the world. it reaches this worldwide market by combining the
